Elena Crisà

A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

Elena Crisà, Ermanno Venturino, Roberto Passera et al. · Annals of Hematology · 2010 · 59 citations · Full text

Hematological Malignancy, Thrombosis, Laboratory Hematology +9

Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study

Aytug Kizilors, Elena Crisà, Nicholas Lea et al. · The Lancet Haematology · 2019 · 55 citations

Hematological Malignancy, Cancer Research, Population-based Study +13

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Köster, Laurien Baaij et al. · Blood Advances · 2024 · 54 citations · Full text

Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohort

Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale et al. · American Journal of Hematology · 2023 · 39 citations · Full text

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

Massimo Breccia, Luigiana Luciano, Roberto Latagliata et al. · Leukemia Research · 2014 · 34 citations

Hematological Malignancy, Concomitant Comorbidities, Aging +10